Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ibrutinib Tablets

Approval Number

国药准字H20253032

Company齐鲁制药（海南）有限公司

Registration Date

January 2, 2025

Drug Information

Generic Name

伊布替尼片

Dosage Form

片剂

Strength

0.56g

Drug Type

化学药品

Registration Date

January 2, 2025

Company Information

Applicant Company

Company Name齐鲁制药（海南）有限公司

Company Address

海口市国家高新区南海大道273号-A

Manufacturing Company

Company Name齐鲁制药（海南）有限公司

Company Address

海口市国家高新区南海大道273号-A

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

伊布替尼片 - NMPA 批准文号 | MedPath